Nissay Asset Management Corp Eli Lilly & CO Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Nissay Asset Management Corp holds 172,782 shares of LLY stock, worth $130 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

172,782

Previous 215,080 19.67%

Holding current value

$130 Million

Previous $195 Million 21.39%

% of portfolio

0.99%

Previous 1.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $32.7 Million - $40.6 Million	-42,298 Reduced 19.67%	172,782 $153 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $5.25 Million - $6.59 Million	-7,244 Reduced 3.26%	215,080 $195 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $2.27 Million - $3.04 Million	-3,835 Reduced 1.7%	222,324 $173 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $4.75 Million - $5.6 Million	-9,044 Reduced 3.85%	226,159 $132 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $16.8 Million - $23.1 Million	-38,607 Reduced 14.1%	235,203 $126 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $9.67 Million - $12.9 Million	-27,566 Reduced 9.15%	273,810 $128 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $61.8 Million - $72.6 Million	198,923 Added 194.16%	301,376 $103 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1.22 Million - $1.42 Million	-3,783 Reduced 3.56%	102,453 $37.5 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $909,007 - $1.04 Million	3,066 Added 2.97%	106,236 $34.4 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $53,794 - $63,163	-193 Reduced 0.19%	103,170 $33.5 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $388,881 - $483,280	1,657 Added 1.63%	103,363 $29.6 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.99 Million - $3.71 Million	13,287 Added 15.03%	101,706 $28.1 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $1.64 Million - $2.02 Million	7,403 Added 9.14%	88,419 $20.4 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $32,137 - $41,570	178 Added 0.22%	81,016 $18.6 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $353,123 - $457,135	-2,149 Reduced 2.59%	80,838 $15.1 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $709,050 - $938,244	-5,435 Reduced 6.15%	82,987 $14 Million
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $1.85 Million - $2.14 Million	-12,642 Reduced 12.51%	88,422 $13.1 Million
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $756,176 - $910,049	-5,543 Reduced 5.2%	101,064 $16.6 Million
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $275,124 - $340,525	2,311 Added 2.22%	106,607 $14.8 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $529,147 - $655,396	-4,949 Reduced 4.53%	104,296 $13.7 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $57,453 - $62,494	-538 Reduced 0.49%	109,245 $12.2 Million
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $1.32 Million - $1.54 Million	-11,935 Reduced 9.81%	109,783 $12.2 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $601,519 - $708,032	-5,404 Reduced 4.25%	121,718 $15.8 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $206,399 - $231,229	1,949 Added 1.56%	127,122 $14.7 Million
Q3 2018 Oct 30, 2018	BUY	$85.86 - $107.31 $148,709 - $185,860	1,732 Added 1.4%	125,173 $13.4 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $995,379 - $1.14 Million	-13,149 Reduced 9.63%	123,441 $10.5 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $323,258 - $381,585	4,356 Added 3.29%	136,590 $10.6 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $10.8 Million - $11.6 Million	132,234	132,234 $11.2 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Eli Lilly & CO Transaction History